1. DSpace BSMU (Chernivtsy, Ukraine)
  2. Підрозділи БДМУ
  3. Кафедри
  4. Внутрішньої медицини
  5. Статті
Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26160
Title: Cost-effectiveness analysis of infliximab versus CinnoRA in the treatment of moderate to severe ulcerative colitis in Iranian patients
Authors: Olfatifar, M.
Asadzadeh Aghdaei, H.
Hasanpour Dehkordi, A.
Shahrokh, S.
Pourhoseingholi, M.A.
Balaii, H.
Mohsen Rajabnia, M.
Ivanchuk, Maria
Ivanchuk, Pavlo
Hashemi Nazari, S.
Sabour, S.
Rohani, P.
Mehralian, G.
Khodakarim, S.
Hatami, B.
Malekpour, H.
Sherkat, G.
Zali, M.R.
Rahimi Pordanjani, S.
Keywords: Cost-effectiveness
infliximab
CinnoRA
Ulcerative colitis
Microsimulation
Issue Date: 2023
Publisher: Immunopathologia Persa (міжнародний рецензований журнал)
Abstract: Objectives: This study was done to evaluate the cost-effectiveness of IFX versus CinnoRA for the treatment of moderate-to-severe UC patients. Conclusion: Our results demonstrated that IFX is more effective and more costly than CinnoRA, and if we ignore the predicted surgeries, CinnoRA is nearly as effective as IFX. However, these findings should be cautiously interpreted without a robust clinical trial of CinnoRA in UC patients. Since the impact of CinnoRA may have been over/underestimated.
URI: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26160
Appears in Collections:Статті

Files in This Item:
File Description SizeFormat 
Olfatifar M. et al. Cost-effectiveness_1-9_2023.pdf276.56 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.